Trial Profile
CSP 442 - Warfarin and Antiplatelet Therapy Study in Patients With Congestive Heart Failure (WATCH)
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 07 Aug 2018
Price :
$35
*
At a glance
- Drugs Aspirin (Primary) ; Clopidogrel (Primary) ; Warfarin (Primary)
- Indications Cardiovascular disorders; Chronic heart failure; Heart failure
- Focus Adverse reactions
- Acronyms WATCH
- 05 Nov 2010 New trial record.